Reporter Oct 26 2012

Wiesner to lead new hereditary cancer program

Georgia Wiesner, M.D., M.S., has joined Vanderbilt-Ingram Cancer Center (VICC) as professor of Medicine and director of the newly created Clinical and Translational Hereditary Cancer Program.

Combined drug therapy may delay melanoma progression

Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene.

Hamm’s research honored by Dutch pharmacology society

Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society.

Project targets sickle cell disease in Nigeria

Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria.

Nurses group names VUMC top employer

Vanderbilt University Medical Center has been named the Employer of the Year for 2012 by the Tennessee Nurses Association (TNA).

Nurses’ investigative efforts highlighted at Research Day

A bright spotlight shone on nursing research at Vanderbilt University Medical Center during the Evidence-Based Practice and Nursing Research Committee’s annual Research Day on Oct. 17.

1 2